Enanta Pharmaceuticals, Inc. (ENTA)

Enanta Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	44.81	37.23	85.39	43.99	57.21	87.13
Short-Term Investments	159.3	210.95	284.52	205.24	186.8	299.52
Cash & Short-Term Investments	204.11	248.19	369.91	249.23	244	386.65
Cash Growth	-11.29%	-32.91%	48.42%	2.14%	-36.89%	15.34%
Accounts Receivable	8.33	6.65	8.61	20.32	23.58	23.49
Other Receivables	0.02	32	31	28.72	37.26	13.04
Receivables	8.36	38.65	39.62	49.04	60.83	36.53
Prepaid Expenses	10.24	12.41	13.26	13.45	14.19	13.66
Restricted Cash	-	0.61	-	-	-	-
Total Current Assets	222.71	299.85	422.79	311.71	319.02	436.84
Property, Plant & Equipment	74.87	73.35	34.71	29.75	10.65	15.62
Long-Term Investments	-	-	-	29.29	108.42	32.63
Long-Term Deferred Tax Assets	-	-	-	-	-	0.35
Other Long-Term Assets	3.45	3.45	4.77	4.66	0.7	0.7
Total Assets	301.03	376.65	462.28	375.41	438.79	486.13
Accounts Payable	3.55	8	4.1	6	9.54	5.74
Accrued Expenses	10.85	13.55	18.34	20.94	22.43	14.16
Current Portion of Long-Term Debt	27.76	34.46	35.08	-	-	-
Current Portion of Leases	2.39	1.52	5.28	2.89	4.2	4.26
Total Current Liabilities	44.55	57.54	62.79	29.83	36.17	24.16
Long-Term Debt	121.29	136.13	160.85	1.42	1.51	1.48
Long-Term Leases	55.66	53.94	21.24	22.37	1.13	3.84
Other Long-Term Liabilities	0.25	0.23	0.66	0.45	0.56	1.08
Total Liabilities	221.75	247.84	245.54	54.08	39.36	30.55
Common Stock	0.21	0.21	0.21	0.21	0.2	0.2
Additional Paid-In Capital	465.7	451.34	424.69	398.03	351.03	326.96
Retained Earnings	-386.23	-323.04	-207	-73.18	48.58	127.57
Comprehensive Income & Other	-0.4	0.3	-1.17	-3.72	-0.38	0.84
Shareholders' Equity	79.28	128.81	216.74	321.33	399.43	455.58
Total Liabilities & Equity	301.03	376.65	462.28	375.41	438.79	486.13
Total Debt	207.1	226.06	222.44	26.69	6.84	9.58
Net Cash (Debt)	-2.99	22.13	147.47	251.83	345.58	409.71
Net Cash Growth	-	-85.00%	-41.44%	-27.13%	-15.65%	2.86%
Net Cash Per Share	-0.14	1.05	7.03	12.22	17.13	20.55
Filing Date Shares Outstanding	21.38	21.19	21.06	20.8	20.32	20.08
Total Common Shares Outstanding	21.38	21.19	21.06	20.79	20.24	20.08
Working Capital	178.16	242.32	360	281.89	282.85	412.68
Book Value Per Share	3.71	6.08	10.29	15.46	19.74	22.69
Tangible Book Value	79.28	128.81	216.74	321.33	399.43	455.58
Tangible Book Value Per Share	3.71	6.08	10.29	15.46	19.74	22.69
Machinery	20.36	19.92	19.14	16.79	16.32	15.82
Construction In Progress	1.35	22.75	1.27	2.56	0.02	-
Leasehold Improvements	36.82	13.98	13.8	7.28	7.14	7.09

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q